DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,654 | -11.5% | 10 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $3,000 | -57.1% | 10 | -63.0% | 0.00% | -50.0% |
Q2 2022 | $7,000 | +133.3% | 27 | +170.0% | 0.00% | +100.0% |
Q1 2022 | $3,000 | -62.5% | 10 | -60.0% | 0.00% | -50.0% |
Q4 2021 | $8,000 | 0.0% | 25 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $8,000 | +14.3% | 25 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $7,000 | +16.7% | 25 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $6,000 | 0.0% | 25 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $6,000 | +20.0% | 25 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $5,000 | -44.4% | 25 | -50.0% | 0.00% | -42.9% |
Q2 2020 | $9,000 | +28.6% | 50 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $7,000 | -84.1% | 50 | -82.5% | 0.01% | -82.1% |
Q4 2019 | $44,000 | -66.7% | 285 | -68.8% | 0.04% | -51.2% |
Q3 2019 | $132,000 | -22.4% | 912 | -23.4% | 0.08% | -14.0% |
Q2 2019 | $170,000 | +1.8% | 1,191 | -5.8% | 0.09% | +5.7% |
Q1 2019 | $167,000 | +27.5% | 1,265 | -0.8% | 0.09% | +31.3% |
Q4 2018 | $131,000 | -5.8% | 1,275 | 0.0% | 0.07% | +4.7% |
Q3 2018 | $139,000 | +13.9% | 1,275 | +2.7% | 0.06% | +6.7% |
Q2 2018 | $122,000 | -3.2% | 1,241 | -3.5% | 0.06% | -3.2% |
Q1 2018 | $126,000 | +12.5% | 1,286 | +7.2% | 0.06% | +17.0% |
Q4 2017 | $112,000 | +15.5% | 1,200 | +6.6% | 0.05% | +3.9% |
Q3 2017 | $97,000 | +2.1% | 1,126 | 0.0% | 0.05% | -1.9% |
Q2 2017 | $95,000 | -10.4% | 1,126 | -8.2% | 0.05% | -10.3% |
Q1 2017 | $106,000 | +7.1% | 1,226 | 0.0% | 0.06% | -4.9% |
Q4 2016 | $99,000 | +6.5% | 1,226 | 0.0% | 0.06% | +7.0% |
Q3 2016 | $93,000 | -29.5% | 1,226 | -6.1% | 0.06% | -30.5% |
Q2 2016 | $132,000 | – | 1,305 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |